These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 9469432

  • 81. Interferon-induced inhibition of Moloney sarcoma virus-transformed cells: requirement for T-cells.
    Skicki-Mullen MB, Markovic SN, Murasko DM.
    Cancer Res; 1989 Feb 01; 49(3):522-7. PubMed ID: 2463077
    [Abstract] [Full Text] [Related]

  • 82. [The antitumor effect and immuno-mechanism of IL-23 in mouse mammary cancer].
    Feng YL, Liu S, Shao LL, Shan BE.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep 01; 24(9):853-6. PubMed ID: 18782514
    [Abstract] [Full Text] [Related]

  • 83. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
    Shitara K, Ichimura O, Mitsuno T, Osawa T.
    J Immunol; 1985 Feb 01; 134(2):1039-47. PubMed ID: 2578148
    [Abstract] [Full Text] [Related]

  • 84. Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts.
    Zitvogel L, Tahara H, Robbins PD, Storkus WJ, Clarke MR, Nalesnik MA, Lotze MT.
    J Immunol; 1995 Aug 01; 155(3):1393-403. PubMed ID: 7636204
    [Abstract] [Full Text] [Related]

  • 85. An IL-12/Shh-C domain fusion protein-based IL-12 autocrine loop for sustained natural killer cell activation.
    Zhu L, Zhao Z, Wei Y, Marcotte W, Wagner TE, Yu X.
    Int J Oncol; 2012 Aug 01; 41(2):661-9. PubMed ID: 22581115
    [Abstract] [Full Text] [Related]

  • 86. The antitumor effects of IFN- beta against human renal cell carcinoma in athymic nude mice.
    Shirahama T, Kayajima T, Ohi Y.
    In Vivo; 1989 Aug 01; 3(5):345-9. PubMed ID: 2519876
    [Abstract] [Full Text] [Related]

  • 87. Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts.
    Murphy WJ, Back TC, Conlon KC, Komschlies KL, Ortaldo JR, Sayers TJ, Wiltrout RH, Longo DL.
    J Clin Invest; 1993 Oct 01; 92(4):1918-24. PubMed ID: 8408644
    [Abstract] [Full Text] [Related]

  • 88. Correlation of immunomodulatory and therapeutic activities of interferon and interferon inducers in metastatic disease.
    Black PL, Phillips H, Tribble HR, Pennington R, Schneider M, Talmadge JE.
    J Cell Biochem; 1988 Apr 01; 36(4):377-92. PubMed ID: 3132467
    [Abstract] [Full Text] [Related]

  • 89. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
    Asada H, Kishida T, Hirai H, Satoh E, Ohashi S, Takeuchi M, Kubo T, Kita M, Iwakura Y, Imanishi J, Mazda O.
    Mol Ther; 2002 May 01; 5(5 Pt 1):609-16. PubMed ID: 11991752
    [Abstract] [Full Text] [Related]

  • 90. In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites.
    Micallef MJ, Yoshida K, Kawai S, Hanaya T, Kohno K, Arai S, Tanimoto T, Torigoe K, Fujii M, Ikeda M, Kurimoto M.
    Cancer Immunol Immunother; 1997 Jan 01; 43(6):361-7. PubMed ID: 9067408
    [Abstract] [Full Text] [Related]

  • 91. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent.
    Smyth MJ, Taniguchi M, Street SE.
    J Immunol; 2000 Sep 01; 165(5):2665-70. PubMed ID: 10946296
    [Abstract] [Full Text] [Related]

  • 92. Sarcoma cells engineered to secrete IFN-gamma or IL-2 acquire sensitization to immune cell killing via different mechanisms.
    Flemming CL, Patel PM, Box G, Eccles SA, Collins MK.
    Cytokine; 1997 May 01; 9(5):328-32. PubMed ID: 9195131
    [Abstract] [Full Text] [Related]

  • 93. Immunostimulation-mediated antitumor activity by preconditioning with rice-shochu distillation residue against implanted tumor in mice.
    Seki T, Morimura S, Ohba H, Tang Y, Shigematsu T, Maeda H, Kida K.
    Nutr Cancer; 2008 May 01; 60(6):776-83. PubMed ID: 19005977
    [Abstract] [Full Text] [Related]

  • 94. INAM plays a critical role in IFN-γ production by NK cells interacting with polyinosinic-polycytidylic acid-stimulated accessory cells.
    Kasamatsu J, Azuma M, Oshiumi H, Morioka Y, Okabe M, Ebihara T, Matsumoto M, Seya T.
    J Immunol; 2014 Nov 15; 193(10):5199-207. PubMed ID: 25320282
    [Abstract] [Full Text] [Related]

  • 95. Interleukin 12 gene transfer into skin distant from the tumor site elicits antimetastatic effects equivalent to local gene transfer.
    Oshikawa K, Rakhmilevich AL, Shi F, Sondel PM, Yang N, Mahvi DM.
    Hum Gene Ther; 2001 Jan 20; 12(2):149-60. PubMed ID: 11177552
    [Abstract] [Full Text] [Related]

  • 96. Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.
    Marshall NA, Galvin KC, Corcoran AM, Boon L, Higgs R, Mills KH.
    Cancer Res; 2012 Feb 01; 72(3):581-91. PubMed ID: 22158905
    [Abstract] [Full Text] [Related]

  • 97. IL-7 inhibits tumor growth by promoting T cell-mediated antitumor immunity in Meth A model.
    Tang JC, Shen GB, Wang SM, Wan YS, Wei YQ.
    Immunol Lett; 2014 Feb 01; 158(1-2):159-66. PubMed ID: 24406503
    [Abstract] [Full Text] [Related]

  • 98. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.
    Okamoto M, Ohe G, Furuichi S, Nishikawa H, Oshikawa T, Tano T, Ahmed SU, Yoshida H, Moriya Y, Matsubara S, Ryoma Y, Saito M, Sato M.
    Anticancer Res; 2002 Feb 01; 22(6A):3229-39. PubMed ID: 12530069
    [Abstract] [Full Text] [Related]

  • 99. Regression of engineered myeloma cells secreting interferon-gamma-inducing factor is mediated by both CD4(+)/CD8(+) T and natural killer cells.
    Xiang J, Chen Z, Huang H, Moyana T.
    Leuk Res; 2001 Oct 01; 25(10):909-15. PubMed ID: 11532525
    [Abstract] [Full Text] [Related]

  • 100. IL-28 elicits antitumor responses against murine fibrosarcoma.
    Numasaki M, Tagawa M, Iwata F, Suzuki T, Nakamura A, Okada M, Iwakura Y, Aiba S, Yamaya M.
    J Immunol; 2007 Apr 15; 178(8):5086-98. PubMed ID: 17404291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.